Christeyns secures EU BPR approval for peracetic acid dossier
- Approval published in the Official Journal of the European Union on 25 September 2026.
- The dossier covers peracetic acid (PAA) biocidal products under the Biocidal Products Regulation (BPR).
- The approval follows more than ten years of investment, research and cross-department collaboration.
- Product documentation and labels will be updated and BPR-compliant products will be gradually introduced across European markets.
Approval recorded
Christeyns' Peracetic Acid (PAA) Biocidal Products Regulation (BPR) dossier was approved and published in the Official Journal of the European Union on 25 September 2026.
Scope and evaluation
PAA plays a role in a wide range of hygiene and disinfection applications; the BPR approval indicates the products and applications covered by the dossier have undergone extensive scientific evaluation and meet the regulation’s requirements, providing a harmonised regulatory framework across Europe for the authorised uses.
Project effort
The approval is the result of more than a decade of investment, research and collaboration among Regulatory Affairs, R&D, Applications, Manufacturing, Purchasing and Sales teams that navigated one of the industry’s most demanding regulatory processes.
Implications and next steps
The approval begins an implementation phase: product documentation and labels will be updated to align with the approved dossier, and BPR-compliant products will be gradually introduced across European markets, offering customers solutions supported by the regulatory framework and scientific evaluation.
Source: Christeyns